Pfizer Case Study Imaginatik Front End Vienna 2008 v7

Embed Size (px)

Citation preview

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    1/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 1

    The Third

    QuestionFront End of Innovation

    28-31 January 2008Vienna

    Dr Robin W. SpencerSenior Research Fellow

    Pfizer, Inc.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    2/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 2

    Take Home Message

    In a fast-paced, complex, uncertain world, you must beable to pull resources to problems with speed andefficiency.

    Idea management systems are well suited to this need.

    But novel things must also be pushed on a resistantorganization; it will not change on its own.

    Therefore we push in many small different ways,achieving short-term real results, which can also drive along-term culture change frompush topull.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    3/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 3

    Many Thanks

    Steve Street

    Mark Turrell, Geoff Carss,& Cameron Snider

    2008 DavosTechnology Pioneer

    award winner

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    4/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 4

    Why

    The First Question

    Whydo we need to drive innovation ?Very large forces are acceleratingchange :

    geopoliticslower barriers to movement of people and goods, especially in Europe and Asia

    demographics and resourcesretirement of the Baby Boomers, end of plentiful oil, onset of climate change

    internetinformation and money now travel globally, essentially free

    Make these enablers, not threats !

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    5/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 5

    What

    The Second Question

    Whydo we need to drive innovation ?

    Whatdo we need to do ?

    We know this !

    manage the detailsSaving time, money, and squeezing out waste is good but not enough.

    listen to the edgesReal change does not come by optimizing the status quo. The edges inside andoutside your organization are where the new ideas are found.

    have open and flexible systemsThe last thing you need are risk-averse policies and systems that slow you down.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    6/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 6

    What to do: Push vs. Pull

    Push and Pull are different strategiesfor directing resources to achieve agoal or fix a problem.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    7/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 7

    Push vs. Pull

    Push is traditional: analysis, decisions,and planning are done beforepushingresources at targeted goals or problems

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    8/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 8

    Push vs. Pull

    but if the world is too uncertain,complex, or fast-changing, then push isineffective.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    9/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 9

    Push vs. Pull

    Pull is more dynamic: you ride theproblem andpull resources as needed...

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    10/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 10

    Push vs. Pull

    which takes agility: rapid access toinformation, quick decision-making,and adaptive supply systems.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    11/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 11

    How

    The Third Question

    Whydo we need to drive innovation ?Whatdo we need to do ?

    Howdo we do it ?

    Someone has to take

    some risks and learn,out on the streets

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    12/35Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 12

    How to innovate: Push vs. Pull

    known and valuable,then customers will PULL

    novel and uncertain,then you must PUSHif all you do is build it, they wont come !

    If what you offer is

    perceived as

    This is just as true for innovationinside your organization,as it is for retail marketing.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    13/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 13

    A

    The Third Man* onInnovation

    * Graham Greene wrote the book and screenplay. Orson Welles ad-libbed just one line -- this, the most memorable one of the film.

    In Italy for 30 years under the

    Borgias they had warfare, terror,murder, and bloodshed, but theyproduced Michelangelo, Leonardoda Vinci, and the Renaissance.

    In Switzerland they had brotherlylove - they had 500 years ofdemocracy and peace, and whatdid that produce ?

    The cuckoo clock.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    14/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 14

    How to innovate: One Step at a Time

    How to change the world:

    1. Have a vision of the future.

    2. Act like its already true.

    3. Repeat.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    15/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 15

    How to innovate: One Step at a Time

    Pushing a biginnovation project can

    get bogged down inparalysis-by-analysis

    ...so insteadwevebeen driving hundredsof mid-size initiatives,rapidly implemented.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    16/35

    16

    Case Studies fromPfizer Global Research &Development

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    17/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 17

    Summary

    Since the Idea Farm began in PGRD in early2006, weve run over a hundred campaigns

    of all scales and types.

    Of course they arent all gems but quite afew are ! These case studies highlight thediversity and value achieved in the past twoyears.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    18/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 18

    The Structure of a Campaign:Diverge, then Converge

    18

    identify theproblem &

    owner

    details ofchallenge &

    audiencelaunch capture ideas

    build outideas

    reviewconclusions

    and decisions

    This is the basic form of a

    problem-solving campaign.

    There are specific tools and

    advice for each step.

    ??

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    19/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 19

    Case Studies by Scale and Type

    social problem-solving

    meeting and decision support

    Continuous Improvement

    outside supplier & partner challenges

    portfolios & priorities : Speed Dates

    portfolios & priorities : large challenges

    long-shot technical challenges

    project management

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    20/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 20

    long shot technical challenges

    These are technical challenges sent to thousands of people. Truly usefulresponses are rare due to the difficulty and scale of the problems;however, payoffs are large.

    ADAPTS: Substrate for Phase 3 Starts

    Of the 100+ entries, most were detailed and serious ideas for secondaryindications. Most did not fit the tight time requirements, but one was

    accepted and funded.

    Formulation and Delivery for Vet Med

    Pharm Sci and Discovery scientists offered significant advice and contact

    info for complex problems in how formulation for humans could beadapted for animals.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    21/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 21

    social problem solving

    These are social challenges sent to thousands of people. No single ideahas great impact, but collectively they support engagement andempowerment, and shape leadership thinking.

    Pfizer Communities

    Hundreds of colleagues in Connecticut and Rhode Island offeredpersonal recommendations and connections to Michigan colleagues,

    helping them to decide on relocation offers. Credited as a factor in our70% acceptance rate.

    Shape your Future Workspace

    Beginning in Sandwich and then extended to all PGRD, colleaguescontributed 345 ideas about space, light, sound, communications to helpkeep the workspace vibrant as occupancy nears capacity.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    22/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 22

    meeting and decision support

    Offsite meetings of 100+ leaders are complex and expensive. Secureevents can capture ideas and drive decisions during such meetings. Theyare a vast improvement over flipcharts and sticky notes!

    Global Operations Leadership Forum

    This team had data-rich, difficult decisions about facility costs to

    manage. This campaign was coordinated with IMPACT methods forreal-time problem solving over 3 days.

    Research Management Committee in Boston

    Very active flash sessions and speed dates resulted in over 500 ideas on

    how to refine and implement a new strategy, which were prioritized andpresented in real time.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    23/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 23

    outside suppliers and partners

    Our outside-the-firewall system can be used to share information, collectideas, route documents, etc., with partners, vendors, academics outside ofPfizer. It is completely secure and separate from our internal Idea Farm.

    Scripps Collaboration

    A continuous high-traffic campaign routes scientific Scripps-generated

    documents for specific review by Pfizer scientists, conclusions by thesteering committee, with contract-compliant reply to Scripps.

    Consulting Collaboration Conference

    As prelude to an all-day meeting in New York, partner firms were askedfor anonymous, candid feedback on how we could get more value fromtheir services.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    24/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 24

    Continuous Improvement

    Idea Farm events can support CI in many ways: by open brainstormingfor ideas, by front-loading Agile Workshops, by providing review-and-conclusion tracking for portfolios of dozens of small improvements, bypaving the way for future communications.

    CAN Smoothing

    Over 200 ideas from all levels of Discovery were substrate for this

    initiative to smooth out a chronic scheduling problem.

    CAN-to-FIH Acceleration

    Scientists and managers ideas fed into multiple workshops, and then a

    two day senior cross-line meeting, resulting in specific decisions thatcould cut a critical pathway to half the current time.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    25/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 25

    portfolios & priorities : Speed Dates

    Speed Dates are intense meetings of rotating 5 minute What do youneed? What do you have? conversations. A custom campaign is veryuseful for capturing the players and topics at speed.

    New Product Opportunities

    A one-day three-stage (speed date, deep date, peer review) meeting in

    New York resulted in 73 previously undocumented ideas that could enterour product pipeline.

    Research Centers of Emphasis Roadshows

    The Research CoEs are small, diverse, specialized units offering

    technical and outsourcing support to all Worldwide Research. In 2 hoursessions, these refined speed date sessions are eliciting many urgent,specific needs from the Therapeutic Areas at the research sites.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    26/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 26

    portfolios & priorities : challenges

    Large challenges are very useful for identifying and prioritizing tasks orresources in portfolios. Here are two good examples :

    Effective Use of Chemistry

    We have major synthetic chemistry outsourcing contracts in Asia.Despite all good tracking, there can be delays resulting in idle time.

    This challenge identified dozens of high value but non-urgent tasks tokeep the docket full.

    What Belongs in the Computing Toolbox?

    After two in-house scientific computing teams reorganized, they

    cosponsored a single challenge to all Research, to identify and developneeds without regard to line divisions.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    27/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 27

    project management

    The Idea Farms ability to do situational email alerting and trackingmakes it useful in long-duration project management situations.

    Ask the Research CoEs

    In addition to being the home page for the Research CoEs (with allthe usual links and background information), this site solicits and auto-

    routes requests for information and services.

    One Hundred SOPs

    With 100 documents to review and track in a complex matrix of people,

    this campaign uses all of the review-and-conclusion tools to managecomments, changes, and workflow.

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    28/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 28

    Take Home Lessons

    There is no best among these campaigns and

    types of use. Every one was quick to implement andprovided real value to the business.

    Only in hindsight can we say which campaigns havehad the greatest value. Thus the key to success isto be fast, be inexpensive, give the best advice, anddont be too judgemental.

    The most successful initiatives always used multiple

    approaches electronic media, face-to-facemeetings, workshops, etc. in a coordinated way.

    f

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    29/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 29

    references

    John Seely Brown & John Hagel III, Push Pull -- The Next Frontier ofInnovation, McKinsey Quarterly 2005 no 3, 82-91.

    John Hagel & John Seely Brown, From Push to Pull - Emerging Modelsfor Mobilizing Resources, working paper, Oct 2005.

    Gary Pisano, Science Business, 2006, HBR Press

    Gary Hamel, The Future of Management, 2007

    Thomas Friedman, The World is Flat, 2006

    Managing Uncertainty, Harvard Business Review Strategy Under Uncertainty, HBR OnPoint reprint

    Herbert Simon, The Sciences of the Artificial

    Peter Senge, The Fifth Discipline

    Contact informationDr. Robin W. Spencer

    Senior Research Fellow

    Pfizer Global Research & Development

    Eastern Point Road, Groton, CT 06340

    tel 860-441-3946

    [email protected]

    Q i ?

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    30/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 30

    Questions ?

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    31/35

    31

    new concepts

    not yet incorporated into the flow of thetalk, but may fit somewhere !

    O t id I ti

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    32/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 32

    level of relationship

    Outside Innovation

    mergers &acquisitionsallianceshiringcapitalequipmentsupplies

    days

    ,$,103 106 109

    102 103

    101

    101

    CEOVPTeamLeader

    anyone DeptHead

    what

    how much

    how often

    by whom

    We have always gone outside our

    organizations for new things

    O t id I ti

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    33/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 33

    level of relationship

    Outside Innovation

    mergers &acquisitionsallianceshiringcapitalequipmentsupplieswhat

    days

    ,$,103 106 109

    102 103

    101

    101

    CEOVPTeamLeader

    anyone DeptHead

    how much

    how often

    by whom

    Whats Newmini-

    alliances

    problem-

    solvers

    O t id I ti

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    34/35

    Robin W. Spencer, Pfizer, Front End of Innovation, Vienna, January 2008 34

    Outside Innovation

    mergers &acquisitionsallianceshiringcapitalequipmentsupplies

    mini-

    alliances

    problem-

    solvers

    CEOVPTeamLeader

    anyone DeptHead

    level of relationship

    Working faster and cheaper means empoweringpeople lower in our organizations, and makingdecisions based more on written details, and lesson personal relationships and trust.

    b t t

  • 8/4/2019 Pfizer Case Study Imaginatik Front End Vienna 2008 v7

    35/35

    abstract

    16:00 Idea Management as an Enabler of the Pull

    Business ModelWhen the business environment is known, predictable, controllable, itis appropriate to push resources at problems. However, when the

    environment uncertain, complex, and not fully controllable, it is betterto pull resources to problems in a just-in-time fashion.

    The difficulties lie in the details of such a rapid, flexible, unstructuredapproach, and there is little practical advice in the literature of justhow to implement pull. Fortunately the processes and tools of Idea

    Management are ideally suited to this type of problem solving. In thepast two years, Pfizer Global Research & Development has run over100 structured and documented problem-solving challenges, both

    inside and outside the firewall. Via multiple examples, we willillustrate a number of best worst!) practices, and offer projections forextensions these processes into an even-more fluid future.

    Dr. Robin W. Spencer, Senior Research Fellow, Idea Managementand Innovation, Pfizer Global Research & Development